Furst DE - Search Results

1

Meloxicam: selective COX-2 inhibition in clinical practice.

Furst DE. Furst DE. Semin Arthritis Rheum. 1997 Jun;26(6 Suppl 1):21-7. doi: 10.1016/s0049-0172(97)80049-2. Semin Arthritis Rheum. 1997. PMID: 9219316 Review.

2

The efficacy and safety of low-dose corticosteroids for rheumatoid arthritis.

Caldwell JR, Furst DE. Caldwell JR, et al. Among authors: furst de. Semin Arthritis Rheum. 1991 Aug;21(1):1-11. doi: 10.1016/0049-0172(91)90051-z. Semin Arthritis Rheum. 1991. PMID: 1948096 Review.

3

Proposition: methotrexate should not be the first second-line agent to be used in rheumatoid arthritis if NSAIDs fail.

Furst DE. Furst DE. Semin Arthritis Rheum. 1990 Oct;20(2):69-75. doi: 10.1016/0049-0172(90)90019-c. Semin Arthritis Rheum. 1990. PMID: 2251507 Review.

4

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis.

Felson DT, Anderson JJ, Boers M, Bombardier C, Furst D, Goldsmith C, Katz LM, Lightfoot R Jr, Paulus H, Strand V, et al. Felson DT, et al. Arthritis Rheum. 1995 Jun;38(6):727-35. doi: 10.1002/art.1780380602. Arthritis Rheum. 1995. PMID: 7779114

5

Are there differences among nonsteroidal antiinflammatory drugs? Comparing acetylated salicylates, nonacetylated salicylates, and nonacetylated nonsteroidal antiinflammatory drugs.

Furst DE. Furst DE. Arthritis Rheum. 1994 Jan;37(1):1-9. doi: 10.1002/art.1780370102. Arthritis Rheum. 1994. PMID: 7818626 Review. No abstract available.

6

Should methotrexate be used to treat early rheumatoid arthritis?

Furst DE. Furst DE. Semin Arthritis Rheum. 1994 Jun;23(6 Suppl 2):39-43. doi: 10.1016/0049-0172(94)90083-3. Semin Arthritis Rheum. 1994. PMID: 7939730 Review.

7

Comparing the strengths and weaknesses of observational and experimental studies using a postmarketing surveillance study as a protypic example.

Furst DE. Furst DE. Semin Arthritis Rheum. 1993 Oct;23(2 Suppl 1):57-61. doi: 10.1016/s0049-0172(10)80008-3. Semin Arthritis Rheum. 1993. PMID: 8278819

8

The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials.

Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, Furst D, Goldsmith C, Kieszak S, Lightfoot R, et al. Felson DT, et al. Arthritis Rheum. 1993 Jun;36(6):729-40. doi: 10.1002/art.1780360601. Arthritis Rheum. 1993. PMID: 8507213

9

Differential effects of diclofenac and aspirin on serum glutamic oxaloacetic transaminase elevations in patients with rheumatoid arthritis and osteoarthritis.

Furst DE, Anderson W. Furst DE, et al. Arthritis Rheum. 1993 Jun;36(6):804-10. doi: 10.1002/art.1780360610. Arthritis Rheum. 1993. PMID: 8507222 Clinical Trial.

10

Update on clinical trials in the rheumatic diseases.

Furst DE. Furst DE. Curr Opin Rheumatol. 1998 Mar;10(2):123-8. doi: 10.1097/00002281-199803000-00007. Curr Opin Rheumatol. 1998. PMID: 9567207 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

735 results

Search Page

Filters